Please login or register first to view this content.
Musculoskeletal Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Pamrevlumab Fast Tracked for Duchenne Muscular Dystrophy
Do Successive Transfers of an Emergency Patient Amount to an EMTALA Violation?
AbbVie Seeks Approval of Risankizumab for Psoriatic Arthritis
Experts Address Osteoporosis Therapy and COVID-19 Vaccination
FDA Panel Votes on Tanezumab for Osteoarthritis Pain
Rates of Drug Treatment for Osteoporosis Low in the US
Guselkumab Benefits Observed Through 2 Years in Psoriatic Arthritis Trial
Long-Term Data Demonstrate Sustained Efficacy of Risdiplam in Spinal Muscular Atrophy
Zolgensma Benefits Observed in Presymptomatic SMA Patients
No Effect of Low-Dose Atorvastatin Found for Muscle Symptoms
Actemra Gains New Indication for Systemic Sclerosis-Associated Interstitial Lung Disease
Amondys 45 Approved for Duchenne Muscular Dystrophy
Fatigue Assessment Included in Simponi Aria Labeling
FDA Approves 3D Printed Implant for Avascular Necrosis of the Talus
Managing RA: Consider Potential Interactions With JAK Inhibitors
WellDyne to Provide Physician Access to Scipher Medicine’s PrismRA Blood Test
Tofacitinib vs TNFi for RA: Safety Study Results Announced
Digital Health App Tracks Pain Progress With Neurostimulation Therapy
